Notably, the abnormal glycosylation of Hp, as well as its potential application for cancer diagnosis and prognosis, has been well documented in prostate, colon, liver, lung, cervix, uterus, and ovary cancers [15–19]. The gene discussed is HP; the disease is cancer.